BioSpace News Archive

Avance Biosciences (Avance), a leading CRO that provides GLP/CGMP-compliant biological testing services that aid drug development and manufacturing, announced today that it has signed a licensing agreement with SeQure Dx, a cutting-edge gene-editing diagnostics company.

Centinel Spine®, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, announced significant expansion to patient access for the prodisc® L Lumbar Total Disc Replacement system.

Masimo (NASDAQ: MASI) today announced that its management will participate in the 44th Annual Raymond James Institutional Investors on Tuesday, March 7, 2023 at 11:00 a.m. Eastern Time.

AstraZeneca and Merck (NYSE: MRK) today announced that the U.S. Food and Drug Administration (FDA) will convene a meeting of the Oncologic Drugs Advisory Committee (ODAC) to discuss the supplemental new drug application (sNDA) for use of LYNPARZA in combination with abiraterone and prednisone or prednisolone (abi/pred) for the treatment of adult patients with metastatic castration-resistant prostate cancer (mCRPC).

IAVI announced today the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, funded additional development and testing of IAVI’s single-dose vaccine candidates against the filoviruses Marburg virus (MARV) and Sudan ebolavirus (SUDV).

Biofrontera, Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products will be presenting at the 35th Annual ROTH Conference in Laguna Nigel, CA being held March 12-14, 2023.

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) today announced that the European Patent Office (“EPO”) has granted European Patent No. EP 3886813, covering the innovative formulation of Hepion’s lead cyclophilin inhibitor, rencofilstat.

InnerScope Hearing Technologies Inc., an emerging and disruptive leader in the Over-the-Counter Hearing Aid space announced together with its subsidiary, HearingAssist Inc.

TeraPore Technologies, the developer of advanced nanofiltration membrane systems for biomanufacturing, announced it has raised $10M in new financing.

Indivior PLC (LSE: INDV) (“Indivior” or the “Company”) today announced that it has completed the acquisition of Opiant Pharmaceuticals, Inc. (“Opiant”).